AnandRathi

Kabra Drugs Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
20.49
-0.44 (-2.10%)

Kabra Drugs Ltd (Kabra Drugs) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹49 crore.

Kabra Drugs Ltd Overview

Market cap₹49 Crs
Volume78,603
Prev. Close₹20.93
Year range₹15.50 - ₹35.52
Total Value₹16,10,575.47
ISININE323K01017

Kabra Drugs Ltd Fundamental Analysis

ROCE(TTM)19.05%
P/E Ratio (TTM)6.40
P/B Ratio1.64
Debt to Equity0.02
ROE16.75%
EPS (TTM)3.20
Dividend Yield0.00%
Book Value12.49
Profit Margin5.76%
Operating Margin6.48%

Kabra Drugs Ltd Historical Performance

1 Month Return-18.88%
6 Month Return-32.86%
3 Year Return418.73%
3 Month Return-18.75%
1 Year Return12.09%
5 Year Return278.74%

Kabra Drugs Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research